Eric Venker
CIK 1801917 · President & Immunovant CEO · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$56.92M
Companies
3
Total Filings
83
Lifetime Open-Market Net
-$180.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President & Immunovant CEO | 1,613,063 | $30.04 | $48.46M | -$156.30M | 48 | 2026-05-22 |
| IMVT | Chief Executive Officer | 251,813 | $33.62 | $8.47M | -$342.9K | 3 | 2026-04-09 |
| Roivant Sciences Ltd. (ROIVW) Delisted | President & COO | 611,813 | $2.75 | $1.68M | -$23.37M | 32 | 2023-08-24 |
Recent Filings · Page 9 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-01 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | −34,428 | -$165.1K | EDGAR |
| 2022-03-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −80,045 | -$405.0K | EDGAR |
Showing 81–83 of 83
Prev
Page 9 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.